Exact Sciences Corp (EXAS)

02:08 AM

How high can Exact Sciences Corporation stock goRate Hike & High Yield Equity Trading Tips - newser.com

02:08 AM

12:07 PM

Published on: 2025-10-12 23:07:32 - newser.com

12:07 PM

Oct 12, 2025

EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 12, 2025

Oct 12, 2025

What’s the recovery path for long term holders of Exact Sciences CorporationNew Guidance & Safe Entry Trade Reports - newser.com

Oct 12, 2025

Oct 12, 2025

Exact Sciences Corporation $EXAS Shares Sold by Blair William & Co. IL - MarketBeat

Oct 12, 2025

Oct 11, 2025

Doyle, Exact Sciences director, sells $120k in shares By Investing.com - Investing.com Australia

Oct 11, 2025

Oct 10, 2025

Herriott James, Exact Sciences SVP, sells $90k in EXAS stock - Investing.com Canada

Oct 10, 2025

Oct 10, 2025

Insider Sell: James Doyle Sells 2,000 Shares of Exact Sciences C - GuruFocus

Oct 10, 2025

Oct 10, 2025

Doyle, Exact Sciences director, sells $120k in shares - Investing.com India

Oct 10, 2025

Oct 10, 2025

Can Exact Sciences Corporation (EXK) stock sustain institutional flowsJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com

Oct 10, 2025

Oct 09, 2025

Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock - Yahoo Finance

Oct 09, 2025

Oct 09, 2025

What analysts say about Exact Sciences Corporation EXK stockFibonacci Extensions & Free Unmatched Market Gains - earlytimes.in

Oct 09, 2025

Oct 08, 2025

Exact Sciences (EXAS): Taking Stock of Valuation Following Recent Share Price Momentum - Yahoo Finance

Oct 08, 2025

Oct 08, 2025

Piper Sandler raises Exact Sciences stock price target to $70 on Cologuard growth - Investing.com India

Oct 08, 2025

Oct 08, 2025

EXAS: Piper Sandler Raises Price Target to $70, Maintains Overwe - GuruFocus

Oct 08, 2025

Oct 08, 2025

Piper Sandler raises Exact Sciences stock price target to $70 on Cologuard growth By Investing.com - Investing.com South Africa

Oct 08, 2025

Oct 08, 2025

Exact Sciences Corp.New Study in Journal of the National Cancer Institute Finds Cologuard Plus Provides the Most Life-Years Gained with the Fewest Colonoscopies - MarketScreener

Oct 08, 2025

Oct 08, 2025

Exact Sciences (NASDAQ:EXAS) Upgraded at Zacks Research - MarketBeat

Oct 08, 2025

Oct 08, 2025

Exact Sciences Corporation $EXAS Shares Bought by Gagnon Securities LLC - MarketBeat

Oct 08, 2025

Oct 08, 2025

Press Release: Exact Sciences Schedules Third Quarter 2025 Earnings Call - 富途牛牛

Oct 08, 2025

Oct 08, 2025

Exact Sciences Schedules Third Quarter 2025 Earnings Call - Business Wire

Oct 08, 2025

Oct 08, 2025

Exact Sciences Corporation $EXAS Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat

Oct 08, 2025

Oct 07, 2025

Evercore ISI Group Raises Price Target for EXAS to $68.00 | EXAS Stock News - GuruFocus

Oct 07, 2025

Oct 07, 2025

Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Here's How Much a $1000 Investment in Exact Sciences Made 10 Years Ago Would Be Worth Today - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Study finds Cologuard Plus efficient for colorectal cancer screening By Investing.com - Investing.com Nigeria

Oct 07, 2025

Oct 07, 2025

Study finds Cologuard Plus efficient for colorectal cancer screening - Investing.com

Oct 07, 2025

Oct 07, 2025

New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies - Yahoo Finance

Oct 07, 2025

Oct 05, 2025

Real time pattern detection on Exact Sciences Corporation stockWeekly Profit Analysis & Weekly High Momentum Picks - newser.com

Oct 05, 2025

Oct 05, 2025

Why Exact Sciences Corporation stock is in analyst buy zone2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Oct 05, 2025

Oct 05, 2025

Will Exact Sciences Corporation see short term momentumTrade Ideas & Fast Moving Market Watchlists - newser.com

Oct 05, 2025

Oct 04, 2025

How Recent Developments Are Reshaping the Story for Exact Sciences - Yahoo Finance

Oct 04, 2025

Oct 03, 2025

Will Analyst Upgrades and Earnings Revisions Shift Exact Sciences' (EXAS) Investment Narrative? - simplywall.st

Oct 03, 2025

Oct 03, 2025

Exact Sciences (EXAS): Evaluating Upside Potential as Analyst Optimism and New Catalysts Drive Attention - simplywall.st

Oct 03, 2025

Oct 03, 2025

Best data tools to analyze Exact Sciences Corporation stockTrade Risk Summary & Technical Pattern Based Signals - newser.com

Oct 03, 2025

Oct 03, 2025

Will Exact Sciences Corporation (EXK) stock announce special dividendEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

How sentiment analysis helps forecast Exact Sciences Corporation2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com

Oct 03, 2025

Oct 03, 2025

Using economic indicators to assess Exact Sciences Corporation potentialTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com

Oct 03, 2025

Oct 03, 2025

Will Exact Sciences Corporation stock deliver consistent dividendsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com

Oct 03, 2025

Oct 02, 2025

Is Exact Sciences Corporation forming a reversal patternJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com

Oct 02, 2025

Oct 02, 2025

EXAS: Barclays Raises Price Target to $65.00 Amid Overweight Rat - GuruFocus

Oct 02, 2025

Oct 02, 2025

Here's Why Exact Sciences (EXAS) is a Strong Growth Stock - Yahoo Finance

Oct 02, 2025

Oct 01, 2025

Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance

Oct 01, 2025

Oct 01, 2025

Published on: 2025-10-01 06:45:18 - newser.com

Oct 01, 2025

Sep 30, 2025

Benchmark raises Exact Sciences stock price target to $60 on cancer test launch - Investing.com

Sep 30, 2025

Sep 30, 2025

Archford Capital Strategies LLC Acquires New Holdings in Exact Sciences Corporation $EXAS - MarketBeat

Sep 30, 2025